FDA Submission & Regulatory Design
Precision-formatted submission documents, briefing books, and advisory committee materials that communicate complex data with clarity and compliance.
Enterprise Life Sciences Marketing
Where Scientific Rigor Meets Bold Vision.
Blue Prospect Studio builds enterprise-grade marketing systems for biopharma, biotech, and life sciences organizations — from clinical trial campaigns to investor relations materials and pipeline launch programs.
NDA-standard confidentiality
MLR-ready workflows
3–5 day enterprise delivery
FDA & regulatory familiar
Compliance-ready by design
Sectors served
Biopharma & BiotechMedical Devices & DiagnosticsLife Sciences SaaSCROs & Clinical ResearchRare Disease ProgramsDigital Health
Why it works
The system is built for what you actually face.
Enterprise life sciences marketing demands more than creative work — it demands regulatory fluency, multi-stakeholder coordination, and the ability to move at the speed of your pipeline. We built our production system specifically for that environment.
- NDA executed before any proprietary science is shared
- AI production engine delivers in days, not months
- Senior scientific and strategic review on every deliverable
- MLR-compatible revision cycles with full audit trails
Enterprise speed. Boutique precision. Regulatory fluency.
3–5 days
Enterprise delivery vs. months at traditional agencies
80%
Faster than incumbent life sciences agencies
NDA ★
Standard confidentiality on every engagement
MLR ✓
Review-ready workflows and full audit trails
Built for the complexity of life sciences
Investor Relations & Capital Markets
Investor decks, roadshow materials, annual reports, and pipeline visualization systems that translate science into compelling financial narratives.
Clinical Trial Recruitment
Multi-channel patient and site recruitment campaigns built to protocol specifications with IRB-review-ready materials.
Pipeline Launch Programs
Full-spectrum commercial launch systems: brand identity, HCP communications, patient education, payer materials, and digital infrastructure.
Scientific Storytelling & Content
Translating complex MOA, clinical data, and pipeline milestones into compelling narratives for every audience — from NEJM to the WSJ.
Enterprise Brand Systems
Comprehensive brand architecture for enterprise biopharma: corporate identity, therapeutic area brands, product brands, and global design standards.
Structured for enterprise rigor.
-
01
Strategic brief & NDA execution Day 1
Mutual NDA executed before any proprietary data is shared. Deep-dive session with your marketing, medical, legal, and regulatory teams to align objectives and constraints.
-
02
System design & stakeholder alignment Day 1–2
We map the full communications ecosystem, identify approval workflows, and design content architecture before a single asset is produced. No surprises downstream.
-
03
AI-accelerated production Day 2–4
Our AI-native production engine generates enterprise-quality assets in days, not months. All output passes senior scientific and strategic review before delivery.
-
04
MLR-ready revision cycles As needed
Structured, documented revision rounds designed to move smoothly through Medical, Legal, and Regulatory review. Complete audit trails maintained throughout.
Enterprise quality. Without the enterprise timeline.
"
We needed investor materials ready for a roadshow in two weeks. Blue Prospect delivered a complete deck system — data visualizations, pipeline narrative, the works — in four days. The board was impressed.
Series C Oncology Biotech
"
I was skeptical that AI-native production could meet the standards our MLR team expects. It did. They understood the approval workflow from day one and structured every deliverable accordingly.
Global Biopharma, Rare Disease Division
"
Our agency had been quoting six months and seven figures for our commercial launch system. Blue Prospect scoped it, produced it, and had us through first MLR review in three weeks.
Pre-Launch Medical Device Company
Scoped for your program. Priced for your stage.
Every engagement is clearly defined before work begins. No open-ended retainers, no scope surprises — just structured deliverables at each stage of your pipeline.
Project-based
5–7 days
FDA submission design, advisory committee materials, briefing books, and regulatory-formatted documents.
ChooseProject-based
7–14 days
Commercial launch systems — brand identity, HCP materials, patient education, payer comms, and digital infrastructure.
ChooseProject-based
3–5 days
Investor decks, roadshow systems, annual report design, and pipeline visualization for capital markets.
ChooseMonthly
Ongoing
Dedicated studio capacity for ongoing pipeline campaigns, content programs, and brand governance.
ChooseReady to see what enterprise-speed looks like?
Tell us about your program. We'll respond within one business day with a capabilities brief tailored to your pipeline stage.